Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept Extension in Ankylosing Spondylitis
NCT00410046Phase 4Completed
- Sponsor
- Pfizer
- Start
- Dec 2006
- Primary completion
- Oct 2008
- Modality
- Fc-Fusion Proteins
- Countries
- 4
01
Overview
A Phase 4 trial of etanercept in ankylosing spondylitis (AS), sponsored by Pfizer. Started Dec 2006; status: completed.
02
Drugs
etanercept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00410046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410046.